Drug Type Biological products |
Synonyms NVQ 042, NVQ042 |
Target |
Action agonists |
Mechanism CTNNB agonists(Beta catenins agonists), Wnt agonists |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetic macular oedema | Preclinical | Belgium | 01 Dec 2024 | |
| Nervous System Diseases | Preclinical | Belgium | 01 Dec 2024 | |
| Wet age-related macular degeneration | Preclinical | Belgium | 01 Dec 2024 |





